{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:48:26Z","timestamp":1741153706556,"version":"3.38.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972312, 81672632"],"award-info":[{"award-number":["81972312, 81672632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2021JJ30912"],"award-info":[{"award-number":["2021JJ30912"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Commission of Hunan Province, China","award":["202102052025"],"award-info":[{"award-number":["202102052025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Pancreatic cancer, a highly invasive and prognostically unfavorable malignant tumor, consistently exhibits resistance to conventional chemotherapy, leading to substantial side effects and diminished patient quality of life. This highlights the critical need for the discovery of novel, effective, and safe chemotherapy drugs. This study aimed to explore bioactive compounds, particularly natural products, as an alternative for JAK2 protein inhibitor in cancer treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Molecular docking, molecular dynamics, and Western blot experiments were conducted to verify the binding of Calothrixin B to JAK2 and its inhibitory effect on the JAK2-STAT3 signaling axis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Recognizing the significant impact of JAK-STAT3 signaling pathway in pancreatic cancer, we screened the Zinc database to discover potential JAK2 inhibitors, and identified the small molecule Calothrixin B as a promising drug. Molecular simulations revealed stable interactions and the formation of hydrogen bonds between Calothrixin B and specific amino acids (Asp 994, Leu 855, and Arg 980) after a 100 ns simulation. Furthermore, we show that Calothrixin B inhibited the activity of the JAK2-STAT3 signaling pathway, arrested pancreatic cancer cells in the G1 phase, induced apoptosis, and significantly inhibited cell migration. Moreover, in vivo on a subcutaneous tumor model in nude mice confirmed that Calothrixin B effectively inhibited tumor growth in nude mice. In addition, the combination of Carlothrixin B and gemcitabine had a better inhibitory effect on pancreatic cancer cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings introduce new avenues for Calothrixin B as promising therapy for pancreatic cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgae149","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T17:53:30Z","timestamp":1737654810000},"page":"404-417","source":"Crossref","is-referenced-by-count":0,"title":["Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma"],"prefix":"10.1093","volume":"77","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed S","family":"Esa","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]},{"name":"Molecular Biology Department, Biotechnology Research Institute, National Research Centre , Giza ,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongji","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif Abdelaziz","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Zoology, Faculty of Science, Cairo University , Giza 12613 ,","place":["Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Sheng","sequence":"additional","affiliation":[{"name":"Hunan Beta Biopharmaceuticals Co. Ltd , Changsha, Hunan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Di","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Applications of Medicinal Plants, Guizhou Medical University; Natural Products Research Center of Guizhou Province , Guiyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-8023","authenticated-orcid":false,"given":"Shubing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, School of Life Sciences, Central South University ; Changsha, Hunan, 410013 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025030500395432800_CIT0001","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025030500395432800_CIT0002","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet (London, England)"},{"key":"2025030500395432800_CIT0003","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"2025030500395432800_CIT0004","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/medicina54030048","article-title":"Chemotherapy in pancreatic cancer: a systematic review","volume":"54","author":"Hajatdoost","year":"2018","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"2025030500395432800_CIT0005","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.3390\/cancers14235725","article-title":"Advances in radiation oncology for pancreatic cancer: an updated review","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"2025030500395432800_CIT0006","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1001\/jamaoncol.2020.3537","article-title":"Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment","volume":"6","author":"van Roessel","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025030500395432800_CIT0007","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-19-3975","article-title":"Integrative genomic analysis of gemcitabine resistance in pancreatic cancer by patient-derived xenograft models","volume":"27","author":"Yang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025030500395432800_CIT0008","doi-asserted-by":"publisher","first-page":"108442","DOI":"10.1016\/j.celrep.2020.108442","article-title":"The natural compound notopterol binds and targets JAK2\/3 to ameliorate inflammation and arthritis","volume":"33","author":"Wang","year":"2020","journal-title":"Cell Rep"},{"key":"2025030500395432800_CIT0009","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijbiomac.2021.12.029","article-title":"High antibacterial and barrier properties of natural rubber comprising of silver-loaded graphene oxide","volume":"195","author":"Li","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"2025030500395432800_CIT0010","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/sj.bjc.6601039","article-title":"Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms","volume":"89","author":"Fukushima","year":"2003","journal-title":"Br J Cancer"},{"key":"2025030500395432800_CIT0011","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.2147\/OTT.S103581","article-title":"Interleukin-32\u03b1 inactivates JAK2\/STAT3 signaling and reverses interleukin-6-induced epithelial\u2013mesenchymal transition, invasion, and metastasis in pancreatic cancer cells","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2025030500395432800_CIT0012","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.bbrc.2017.10.006","article-title":"Fractalkine\/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK\/STAT signaling pathway","volume":"493","author":"Huang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2025030500395432800_CIT0013","doi-asserted-by":"publisher","first-page":"7656031","DOI":"10.1155\/2020\/7656031","article-title":"High JAK2 protein expression predicts a poor prognosis in patients with resectable pancreatic ductal adenocarcinoma","volume":"2020","author":"Song","year":"2020","journal-title":"Dis Markers"},{"key":"2025030500395432800_CIT0014","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/jca.65875","article-title":"Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2\/STAT3 signalling pathway in vivo and in vitro","volume":"13","author":"Xu","year":"2022","journal-title":"J Cancer"},{"key":"2025030500395432800_CIT0015","doi-asserted-by":"publisher","first-page":"22830","DOI":"10.18632\/aging.203575","article-title":"Inhibition of JAK2\/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer","volume":"13","author":"Fan","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"2025030500395432800_CIT0016","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11605-013-2168-7","article-title":"Activation of the IL-6R\/Jak\/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma","volume":"17","author":"Denley","year":"2013","journal-title":"JOGS"},{"key":"2025030500395432800_CIT0017","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/leu.2017.43","article-title":"Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile janus kinase inhibition","volume":"31","author":"Leroy","year":"2017","journal-title":"Leukemia"},{"key":"2025030500395432800_CIT0018","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"2025030500395432800_CIT0019","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12185-010-0531-y","article-title":"The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases","volume":"91","author":"Hitoshi","year":"2010","journal-title":"Int J Hematol"},{"key":"2025030500395432800_CIT0020","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2025030500395432800_CIT0021","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/ci700244t","article-title":"A pharmacophore map of small molecule protein kinase inhibitors","volume":"47","author":"McGregor","year":"2007","journal-title":"J Chem Inf Model"},{"key":"2025030500395432800_CIT0022","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1021\/acsomega.9b02800","article-title":"Insights into the binding recognition and susceptibility of tofacitinib toward janus kinases","volume":"5","author":"Sanachai","year":"2020","journal-title":"ACS Omega"},{"key":"2025030500395432800_CIT0023","doi-asserted-by":"publisher","first-page":"e0132052","DOI":"10.1371\/journal.pone.0132052","article-title":"The topoisomerase 1 inhibitor austrobailignan-1 isolated from koelreuteria henryi induces a G2\/M-phase arrest and cell death independently of p53 in non-small cell lung cancer cells","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"2025030500395432800_CIT0024","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1039\/d0ob02527e","article-title":"Exploiting an intramolecular Diels\u2013Alder cyclization\/dehydro-aromatization sequence for the total syntheses of ellipticines and calothrixin B","volume":"19","author":"Deng","year":"2021","journal-title":"Org Biomol Chem"},{"key":"2025030500395432800_CIT0025","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2025030500395432800_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-019-0371-6","article-title":"Accuracy evaluation and addition of improved dihedral parameters for the MMFF94s","volume":"11","author":"Wahl","year":"2019","journal-title":"J Cheminf"},{"key":"2025030500395432800_CIT0027","first-page":"1","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminf"},{"key":"2025030500395432800_CIT0028","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"2025030500395432800_CIT0029","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J Chem Inf Model"},{"key":"2025030500395432800_CIT0030","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Chem Biol: Methods Protoc"},{"key":"2025030500395432800_CIT0031","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"volume-title":"Software product name. [Software version]","year":"2019","author":"Biovia","key":"2025030500395432800_CIT0032"},{"key":"2025030500395432800_CIT0033","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1080\/07391102.2021.1900917","article-title":"Molecular interaction study of novel indoline derivatives with EGFR-kinase domain using multiple computational analysis","volume":"40","author":"Palanivel","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"2025030500395432800_CIT0034","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J Chem Theory Computat"},{"key":"2025030500395432800_CIT0035","doi-asserted-by":"publisher","first-page":"115242","DOI":"10.1016\/j.bmc.2019.115242","article-title":"A novel phytosterol isolated from Datura inoxia, RinoxiaB is a potential cure colon cancer agent by targeting BAX\/Bcl2 pathway","volume":"28","author":"Gajendran","year":"2020","journal-title":"BMCL"},{"key":"2025030500395432800_CIT0036","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13058-022-01504-4","article-title":"LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c","volume":"24","author":"Deshpande","year":"2022","journal-title":"BCR"},{"key":"2025030500395432800_CIT0037","doi-asserted-by":"publisher","first-page":"108603","DOI":"10.1016\/j.biopha.2019.108603","article-title":"BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells","volume":"112","author":"Yang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2025030500395432800_CIT0038","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12640-018-9988-x","article-title":"Hinokitiol offers neuroprotection against 6-OHDA-induced toxicity in SH-SY5Y neuroblastoma cells by downregulating mRNA expression of MAO\/\u03b1-Synuclein\/LRRK2\/PARK7\/PINK1\/PTEN genes","volume":"35","author":"Varier","year":"2019","journal-title":"Neurotox Res"},{"key":"2025030500395432800_CIT0039","doi-asserted-by":"publisher","first-page":"115960","DOI":"10.1016\/j.bcp.2023.115960","article-title":"A novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase","volume":"219","author":"Zhang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"2025030500395432800_CIT0040","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell Biol"},{"key":"2025030500395432800_CIT0041","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41556-019-0384-4","article-title":"The cell cycle in stem cell proliferation, pluripotency and differentiation","volume":"21","author":"Liu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"2025030500395432800_CIT0042","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ymthe.2022.01.044","article-title":"cGAS\/STING cross-talks with cell cycle and potentiates cancer immunotherapy","volume":"30","author":"Long","year":"2022","journal-title":"Mol Ther"},{"key":"2025030500395432800_CIT0043","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.semcancer.2022.10.009","article-title":"Targeting lactate-related cell cycle activities for cancer therapy","volume-title":"Semin Cancer Biol","author":"Lin","year":"2022"},{"key":"2025030500395432800_CIT0044","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025030500395432800_CIT0045","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"2025030500395432800_CIT0046","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett"},{"key":"2025030500395432800_CIT0047","doi-asserted-by":"publisher","first-page":"603","DOI":"10.6004\/jnccn.2019.5007","article-title":"NCCN guidelines updates: pancreatic cancer","volume":"17","author":"Tempero","year":"2019","journal-title":"JNCCN"},{"key":"2025030500395432800_CIT0048","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025030500395432800_CIT0049","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025030500395432800_CIT0050","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025030500395432800_CIT0051","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2017.05.006","article-title":"BRM\/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2\/STAT3 signaling","volume":"402","author":"Zhang","year":"2017","journal-title":"Cancer Lett"},{"key":"2025030500395432800_CIT0052","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jcp.26892","article-title":"Anticancer effect of SZC015 on pancreatic cancer via mitochondria-dependent apoptosis and the constitutive suppression of activated nuclear factor \u03baB and STAT3 in vitro and in vivo","volume":"234","author":"Song","year":"2019","journal-title":"J Cell Physiol"},{"key":"2025030500395432800_CIT0053","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3892\/or.2014.3478","article-title":"MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol Rep"},{"key":"2025030500395432800_CIT0054","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.compbiolchem.2016.04.009","article-title":"Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors","volume":"64","author":"Itteboina","year":"2016","journal-title":"Comput Biol Chem"},{"key":"2025030500395432800_CIT0055","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1021\/acs.jcim.2c01589","article-title":"Selectivity and ranking of tight-binding JAK-STAT inhibitors using Markovian milestoning with Voronoi tessellations","volume":"63","author":"Ojha","year":"2023","journal-title":"J Chem Inf Model"},{"key":"2025030500395432800_CIT0056","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11030-018-09913-4","article-title":"Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study","volume":"23","author":"Babu","year":"2019","journal-title":"Mol Divers"},{"key":"2025030500395432800_CIT0057","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1021\/ci300308g","article-title":"Regulation of JAK2 activation by Janus homology 2: evidence from molecular dynamics simulations","volume":"52","author":"Wan","year":"2012","journal-title":"J Chem Inf Model"},{"key":"2025030500395432800_CIT0058","doi-asserted-by":"publisher","first-page":"10353","DOI":"10.1039\/c6ra24959k","article-title":"Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors","volume":"7","author":"Yao","year":"2017","journal-title":"RSC Adv"},{"key":"2025030500395432800_CIT0059","doi-asserted-by":"publisher","first-page":"33548","DOI":"10.1021\/acsomega.2c04535","article-title":"Pharmacophore-based virtual screening and experimental validation of pyrazolone-derived inhibitors toward Janus kinases","volume":"7","author":"Sanachai","year":"2022","journal-title":"ACS Omega"},{"key":"2025030500395432800_CIT0060","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ph15010030","article-title":"Molecular modeling insights into upadacitinib selectivity upon binding to JAK protein family","volume":"15","author":"Taldaev","year":"2021","journal-title":"Pharm (Basel, Switzerland)"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/3\/404\/61591583\/rgae149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/3\/404\/61591583\/rgae149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:40:03Z","timestamp":1741135203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/3\/404\/7976897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,1,23]]},"published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgae149","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,1,23]]}}}